(BALN) Baloise Holding - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0012410517

BALN: Insurance, Banking, Asset Management

Baloise Holding AG, a Swiss-based multi-line insurance company founded in 1863, operates across Switzerland, Germany, Belgium, and Luxembourg. The company is structured into four main segments: Non-Life, Life, Asset Management & Banking, and Other Activities. Its Non-Life segment offers a broad range of insurance products, including motor, property, liability, and specialized lines like marine and legal expenses insurance. The Life segment provides traditional and unit-linked life insurance policies, annuities, and group life coverage. The Asset Management & Banking division focuses on wealth management, private banking, and investment services, while the Other Activities segment includes equity investments, real estate holdings, and financing operations.

Baloise serves a diverse customer base, including individuals, SMEs, and industrial clients. The company has a strong presence in Switzerland and is expanding its digital transformation initiatives to enhance customer experience and operational efficiency. Its banking operations are concentrated in Switzerland, offering private banking and wealth management services. Additionally, Baloise has strategic investments in real estate and equity markets, diversifying its revenue streams beyond traditional insurance and banking products. The company is headquartered in Basel, Switzerland, and is listed on the SIX Swiss Exchange under the ticker symbol BALN.

3-Month Forecast: Based on and , Baloise Holding AG is expected to maintain its growth trajectory. The stock is trading above its 20, 50, and 200-day moving averages, indicating bullish momentum. The ATR of 5.44 suggests moderate volatility. With a P/E ratio of 21.92 and a forward P/E of 12.47, the market anticipates earnings growth. The P/B ratio of 2.33 reflects strong book value, while the RoE of 12.66% highlights profitable operations. Over the next three months, Baloise is likely to benefit from its diversified business model, digital transformation efforts, and a stable macroeconomic environment in its core markets.

Additional Sources for BALN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BALN Stock Overview

Market Cap in USD 10,833m
Sector Financial Services
Industry Insurance - Diversified
GiC Sub-Industry Multi-line Insurance
IPO / Inception

BALN Stock Ratings

Growth Rating 60.6
Fundamental 8.70
Dividend Rating 66.5
Rel. Strength 13.3
Analysts -
Fair Price Momentum 198.22 CHF
Fair Price DCF 27.21 CHF

BALN Dividends

Dividend Yield 12m 4.74%
Yield on Cost 5y 7.41%
Annual Growth 5y 3.77%
Payout Consistency 85.9%

BALN Growth Ratios

Growth Correlation 3m 81.4%
Growth Correlation 12m 83.4%
Growth Correlation 5y 66.3%
CAGR 5y 10.85%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 0.56
Alpha 30.98
Beta 0.405
Volatility 36.49%
Current Volume 142k
Average Volume 20d 135.3k
What is the price of BALN stocks?
As of May 02, 2025, the stock is trading at CHF 183.30 with a total of 141,992 shares traded.
Over the past week, the price has changed by -1.53%, over one month by +2.20%, over three months by +15.72% and over the past year by +38.66%.
Is Baloise Holding a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Baloise Holding is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BALN as of May 2025 is 198.22. This means that BALN is currently overvalued and has a potential downside of 8.14%.
Is BALN a buy, sell or hold?
Baloise Holding has no consensus analysts rating.
What are the forecast for BALN stock price target?
According to ValueRays Forecast Model, BALN Baloise Holding will be worth about 214.1 in May 2026. The stock is currently trading at 183.30. This means that the stock has a potential upside of +16.79%.
Issuer Forecast Upside
Wallstreet Target Price 185.6 1.2%
Analysts Target Price - -
ValueRay Target Price 214.1 16.8%